Keppra Alternatives Compared
Keppra Remove Keppra from your drug comparison | Levetiracetam Remove Levetiracetam from your drug comparison | Diastat Remove Diastat from your drug comparison |
---|
Keppra levetiracetam Remove Keppra from your drug comparison | Levetiracetam Remove Levetiracetam from your drug comparison | Diastat diazepam Remove Diastat from your drug comparison | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Keppra is an anticonvulsant that is used in conjunction with other medications for the treatment of certain types of seizure. It may cause drowsiness but it is less likely than some other... View more |
Levetiracetam is an anticonvulsant that is used in conjunction with other medications for the treatment of certain types of seizure. It may cause drowsiness but interactions with other medications... View more |
Prescribed for Status Epilepticus, Seizures. Diastat may also be used for purposes not listed in this medication guide. |
||||||||||||||||
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews |
||||||||||||||||||
Drug Class |
||||||||||||||||||
Side Effects |
||||||||||||||||||
Common side effects include: infection, neurosis, drowsiness, asthenia, headache, nasopharyngitis, nervousness, abnormal behavior, aggressive behavior, agitation, anxiety, apathy, depersonalization, depression, fatigue, hostility, hyperkinetic muscle activity, personality disorder, emotional lability, irritability, laceration, mood changes. See the full Keppra side effects document. |
Commonly reported side effects include: infection, neurosis, drowsiness, asthenia, headache, nasopharyngitis, nervousness, abnormal behavior, aggressive behavior, agitation, anxiety, apathy, depersonalization, depression, fatigue, hostility, hyperkinetic muscle activity, mental disorders, outbursts of anger, personality disorder, emotional lability, irritability, laceration, mood changes. See the full levetiracetam side effects document. |
See the full Diastat side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||
View all Keppra prices and generic prices |
View all levetiracetam prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Generic Availability |
||||||||||||||||||
Yes (this medicine) |
||||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||
|
|
N/A | ||||||||||||||||
Brand Names |
||||||||||||||||||
Other levetiracetam brands include: Elepsia XR, Keppra XR, Roweepra, Roweepra XR, Spritam | Elepsia XR, Keppra, Keppra XR, Roweepra, Roweepra XR, Spritam | Other diazepam brands include: Diastat AcuDial, Diastat Pediatric, Diazepam Intensol, Valium, Valtoco | ||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||
8 hours |
8 hours |
70 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||||||||||
Pregnancy Category |
||||||||||||||||||
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||||||||||
FDA Alerts |
||||||||||||||||||
Drug Interactions |
||||||||||||||||||
A total of 211 drugs are known to interact with Keppra:
|
A total of 211 drugs are known to interact with levetiracetam:
|
A total of 456 drugs are known to interact with Diastat:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||
|
|
|
||||||||||||||||
Disease Interactions |
||||||||||||||||||
First Approval Date |
||||||||||||||||||
November 30, 1999 |
November 30, 1999 |
July 29, 1997 |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information |
||||||||||||||||||
Consumer Resources |
||||||||||||||||||
Professional Resources |
||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.